Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
AIDS (London, England)|September 28, 2016
Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)Alberto C Guardo, Patrick Tjok Joe, Laia Miralles, et al.
Immunobiology|February 16, 2012
Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individualsEster Ballana, Alba Ruiz-de Andres, Beatriz Mothe, et al.
Antiviral Research|May 29, 2018
Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signaturesSandra Franco, Daniela Buccione, Raquel Pluvinet, et al.
Frontiers in Immunology|February 24, 2018
Benzyl-2-Acetamido-2-Deoxy-α-d-Galactopyranoside Increases Human Immunodeficiency Virus Replication and Viral Outgrowth Efficacy <i>In Vitro</i>Alex Olvera, Javier P Martinez, Maria Casadellà, et al.
Trials|June 19, 2019
iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapyWesley de Jong, Joeri Aerts, Sabine Allard, et al.
AIDS (London, England)|November 13, 2015
Balance between activation and regulation of HIV-specific CD8+ T-cell response after modified vaccinia Ankara B therapeutic vaccinationNorma Rallón, Beatriz Mothe, Juan C Lopez Bernaldo de Quiros, et al.
Frontiers in Cellular and Infection Microbiology|September 5, 2025
Interactions between gut microbiota, plasma metabolome and brain function in the setting of a HIV cure trialAlessandra Borgognone, Anna Prats, Ashish Arunkumar Sharma, et al.
Trials|December 15, 2019
Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapyWesley de Jong, Joeri Aerts, Sabine Allard, et al.
Frontiers in Immunology|April 9, 2020
<i>In vivo</i> Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&Kill Clinical TrialMiriam Rosás-Umbert, Marta Ruiz-Riol, Marco A Fernández, et al.
Ebiomedicine|December 10, 2025
PD-1 blockade enhances functional vaccine-induced HIV-1 CD8<sup>+</sup> T-cell responses in PWH receiving early ARTMiguel Marin, Alba Ruiz, Dan Ouchi, et al.
Pageof 10